Creatine and memory claims: read the task, not just the headline

Begin by naming the result you mean

Memory, reasoning, attention, and a general feeling of mental sharpness are not one interchangeable outcome. Researchers may use a particular task to measure one aspect of performance, while a headline uses a much broader word such as cognition. Before deciding that a study answers your question, identify what participants actually did and what changed compared with the control condition.

For example, remembering a sequence of digits is a defined task. It is not identical to remembering appointments, managing medication, or maintaining independent living over years. A study can make a useful contribution without demonstrating every everyday outcome that interests readers. Our monohydrate guide applies a similar distinction to exercise research: a mechanism and a measured result are connected, but they are not the same thing.

A controlled trial found a modest and uncertain signal

A 2023 randomized crossover study included 123 participants and tested working memory and reasoning, with additional exploratory tasks. The abstract reports that one analysis supported a small possible benefit, while the conventional results did not meet the usual significance threshold for either primary task. It found no indication of improvement in the exploratory tasks and reported more side effects during creatine than placebo.

The authors concluded that a small benefit was possible and larger studies were needed. That is more restrained than saying creatine was proved to improve intelligence. It is also more informative than declaring the research worthless because not every analysis pointed the same way. The relevant question is how much uncertainty remains and whether the result addresses your circumstances. The publication reported no competing interests; this review did not independently audit that disclosure.

A pilot in Alzheimer’s disease asks a different question

A 2025 pilot study followed 20 people with Alzheimer’s disease for eight weeks. It examined feasibility and reported increased brain creatine and improvements on some cognitive measures. Crucially, it was a single-arm study: there was no concurrent placebo group providing the comparison needed to determine whether the supplement caused those changes. Its authors called for further efficacy research rather than presenting an established treatment.

A feasibility result can help researchers decide whether a larger trial is practical. It cannot, by itself, distinguish treatment effects from other influences on repeated testing or establish what would have happened without supplementation. The study’s small size and short duration also matter. Its authors disclosed research funding and professional relationships in the publication; those statements are part of the record, not a substitute for examining the design.

Do not turn a study protocol into a shopping instruction

The amounts and schedules researchers use are part of the experiment they designed. They are not automatically appropriate for a reader who sees a similar ingredient in a store. This guide deliberately does not convert either study into a home regimen. A particular dose used under research supervision does not establish a safe or effective personal plan, especially for someone with a diagnosis, medicines, or other health concerns.

The FDA’s supplement information explains the distinction between dietary supplements and products approved as medicines. A seller’s medical-looking website does not transfer a treatment approval to a creatine powder. Our Strong Suit review describes a marketed supplement with a published label and commercial terms; it is not an Alzheimer’s treatment record.

Age and diagnosis are not minor footnotes

A result in one group should not be treated as a result in all adults over 50. People living independently with no cognitive diagnosis, people reporting new symptoms, and people receiving care for Alzheimer’s disease present different questions. A study population can be relevant without being a close match. Look for participants’ health status and the circumstances of testing before borrowing the conclusion for another group.

Our creatine-after-50 article focuses on training evidence, which should stay separate from claims about cognition. Better performance on a strength measure does not demonstrate slower cognitive decline, just as a brain measurement does not demonstrate that someone becomes stronger. A review becomes more useful when it keeps those outcomes visible instead of gathering every favorable result under the broad heading healthy aging.

Check what the advertised product adds to the inference

The studies discussed here do not establish a brand ranking. A manufacturer may use the same ingredient name while selling a product with different additional ingredients, quality documentation, or instructions. An ingredient study does not verify the contents of a purchased batch. Conversely, a useful quality certificate does not establish a memory benefit. These are separate checks even when they appear beside one another on a sales page.

The Myprotein review demonstrates a practical label uncertainty, while the Thorne review discusses a certification record with a defined scope. Neither kind of information can answer a cognitive-efficacy question on its own. Ask a seller which exact study supports the specific claim and whether that study involved the finished product, the relevant population, and the outcome being advertised.

Use the uncertainty to make a better next decision

If memory or concentration has changed, seek an appropriate clinical assessment rather than assuming a supplement addresses the cause. Bring a full list of products and medicines to that conversation. The supplement-list guide shows how to make a concise record; although it focuses on procedure planning, its method of identifying products is useful for other healthcare discussions as well.

For research reading, keep four items together: who participated, what was compared, what was measured, and what remains uncertain. The evidence can be promising enough to justify further study without being strong enough to justify a treatment promise. A creatine review should help you recognize that boundary, not make it disappear beneath a confident headline or a sponsored button.